Medirom Healthcare Technologies Inc. (NASDAQ:MRM – Get Free Report) was the recipient of a significant decline in short interest in the month of June. As of June 15th, there was short interest totaling 136,211 shares, a decline of 59.8% from the May 31st total of 338,625 shares. Based on an average trading volume of 68,176 shares, the short-interest ratio is presently 2.0 days. Currently, 0.8% of the shares of the company are sold short.
Medirom Healthcare Technologies Price Performance
Shares of Medirom Healthcare Technologies stock traded up $0.03 during midday trading on Tuesday, hitting $1.03. 11,817 shares of the company were exchanged, compared to its average volume of 374,815. The firm has a 50 day simple moving average of $1.12 and a 200-day simple moving average of $1.39. Medirom Healthcare Technologies has a 52 week low of $0.90 and a 52 week high of $4.45.
Analyst Ratings Changes
Separately, Weiss Ratings lowered Medirom Healthcare Technologies from a “sell (d+)” rating to a “sell (d)” rating in a report on Thursday, May 28th. One analyst has rated the stock with a Sell rating, According to MarketBeat, Medirom Healthcare Technologies has an average rating of “Sell”.
Medirom Healthcare Technologies Company Profile
MEDIROM Healthcare Technologies Inc provides holistic healthcare services in Japan. It operates in two segments, Relaxation Salon and Digital Preventative Healthcare. The Relaxation Salon segment owns and franchises relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology.
Featured Articles
- Five stocks we like better than Medirom Healthcare Technologies
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
Receive News & Ratings for Medirom Healthcare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medirom Healthcare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
